Critical evaluation of a decision-analytic model of BPH treatment options

Research output: Contribution to journalArticle

Abstract

Therapeutic interventions of benign prostatic hyperplasia (BPH) include surgical procedures, drug treatment with alpha blockers and 5-alpha-reductase inhibitors, and watchful waiting. This month's column presents a step-by-step evaluation of a published decision-analytic model that compares finasteride with both watchful waiting and terazosin. Aside from learning how to critically assess a published pharmacoeconomic study, health care decision makers interested in conducting an economic evaluation in this clinical area can review the inputs used in constructing the original economic evaluation critiqued in this article. Health care decision makers should also take note of the more recent, long-term studies of finasteride used as part of the basis for the economic model. These studies considered acute urinary retention and prostate size, which are more important predictors in successful treatment with finasteride.

Original languageEnglish (US)
Pages (from-to)353-358
Number of pages6
JournalFormulary
Volume35
Issue number4
StatePublished - 2000

Fingerprint

Finasteride
Prostatic Hyperplasia
Watchful Waiting
Terazosin
Cost-Benefit Analysis
5-alpha Reductase Inhibitors
Economic Models
Delivery of Health Care
Pharmaceutical Economics
Urinary Retention
Prostate
Learning
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Critical evaluation of a decision-analytic model of BPH treatment options. / Jones-Grizzle, Amy J.

In: Formulary, Vol. 35, No. 4, 2000, p. 353-358.

Research output: Contribution to journalArticle

@article{ff044d111ce3425bacf95a000776e913,
title = "Critical evaluation of a decision-analytic model of BPH treatment options",
abstract = "Therapeutic interventions of benign prostatic hyperplasia (BPH) include surgical procedures, drug treatment with alpha blockers and 5-alpha-reductase inhibitors, and watchful waiting. This month's column presents a step-by-step evaluation of a published decision-analytic model that compares finasteride with both watchful waiting and terazosin. Aside from learning how to critically assess a published pharmacoeconomic study, health care decision makers interested in conducting an economic evaluation in this clinical area can review the inputs used in constructing the original economic evaluation critiqued in this article. Health care decision makers should also take note of the more recent, long-term studies of finasteride used as part of the basis for the economic model. These studies considered acute urinary retention and prostate size, which are more important predictors in successful treatment with finasteride.",
author = "Jones-Grizzle, {Amy J}",
year = "2000",
language = "English (US)",
volume = "35",
pages = "353--358",
journal = "Formulary",
issn = "1082-801X",
publisher = "Advanstar Communications",
number = "4",

}

TY - JOUR

T1 - Critical evaluation of a decision-analytic model of BPH treatment options

AU - Jones-Grizzle, Amy J

PY - 2000

Y1 - 2000

N2 - Therapeutic interventions of benign prostatic hyperplasia (BPH) include surgical procedures, drug treatment with alpha blockers and 5-alpha-reductase inhibitors, and watchful waiting. This month's column presents a step-by-step evaluation of a published decision-analytic model that compares finasteride with both watchful waiting and terazosin. Aside from learning how to critically assess a published pharmacoeconomic study, health care decision makers interested in conducting an economic evaluation in this clinical area can review the inputs used in constructing the original economic evaluation critiqued in this article. Health care decision makers should also take note of the more recent, long-term studies of finasteride used as part of the basis for the economic model. These studies considered acute urinary retention and prostate size, which are more important predictors in successful treatment with finasteride.

AB - Therapeutic interventions of benign prostatic hyperplasia (BPH) include surgical procedures, drug treatment with alpha blockers and 5-alpha-reductase inhibitors, and watchful waiting. This month's column presents a step-by-step evaluation of a published decision-analytic model that compares finasteride with both watchful waiting and terazosin. Aside from learning how to critically assess a published pharmacoeconomic study, health care decision makers interested in conducting an economic evaluation in this clinical area can review the inputs used in constructing the original economic evaluation critiqued in this article. Health care decision makers should also take note of the more recent, long-term studies of finasteride used as part of the basis for the economic model. These studies considered acute urinary retention and prostate size, which are more important predictors in successful treatment with finasteride.

UR - http://www.scopus.com/inward/record.url?scp=0034049858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034049858&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0034049858

VL - 35

SP - 353

EP - 358

JO - Formulary

JF - Formulary

SN - 1082-801X

IS - 4

ER -